SeaStar Medical Holding Corporation - Common Stock (ICU)

Stay up-to-date with the latest market trends one hour before the close of the markets on Friday. Explore the top gainers and losers during today's session in our detailed report.

The public offer price of $0.65 represents a 33% discount on the stock’s closing price on Wednesday.

Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top gainers and losers in today's session.

The session on Friday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

Discover the top movers in Friday's pre-market session and stay informed about market dynamics.

Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.

In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look.

ICU stock results show that SeaStar Medical Holding beat analyst estimates for earnings per share the second quarter of 2024.

Nuwellis shares are trading higher Monday after the company announced Friday that the first pediatric patient has been treated with the newly launched Quelimmune therapy in a commercial setting.

SeaStar announced that the FDA has agreed to the final labeling for QUELIMMUNE, a novel treatment for children with acute kidney injury and sepsis who require kidney replacement therapy.

ICU stock results show that SeaStar Medical Holding missed analyst estimates for earnings per share the first quarter of 2024.